Scientists at Ohio State have uncovered why cancer immunotherapy often fails, tracing it to the malfunction of T cells burdened by misfolded proteins. Addressing this malfunction could enhance the effectiveness of immunotherapy treatments.
A pivotal study has identified the protein GADD45A as potentially crucial in combating the progression of heart disease, offering fresh pathways for medical intervention.
Researchers from Europe have engineered a synthetic molecule inspired by a natural bacterial compound, showing promise in enhancing chemotherapy effectiveness against cancer.
New research from the Massachusetts Institute of Technology has identified molecules in mucus that can effectively block Salmonella infections. The breakthrough holds promise for developing synthetic versions that could potentially treat or prevent foodborne illnesses.
Renowned for his significant contributions to molecular biology and science policy, David Baltimore's legacy as a pioneering researcher and inspiring leader at MIT and the Whitehead Institute has influenced countless careers and advancements in the field.
Researchers at MIT have made significant strides in reducing the error rate of prime editing, a promising technique with the potential to treat numerous genetic disorders. This advance offers new hope for tackling genetic diseases with enhanced precision and reliability.
A cutting-edge RNA tool developed by SMART promises to enhance the identification of disease markers and foster personalized treatments for cancer and infectious diseases, potentially revolutionizing current medical practices.
MIT scientists unveil VaxSeer, a cutting-edge AI tool that enhances the selection of flu vaccine strains by predicting virus evolution and antigenicity. This innovation aims to significantly improve the efficacy of vaccines and reduce dependence on traditional guessing methods.
Stay informed with curated insights delivered weekly to your inbox.